The trajectory of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced significant uncertainty . Investors are now assessing the impact of generic competit